BR0112497A - Antìgenos de streptococcus pyogenes - Google Patents

Antìgenos de streptococcus pyogenes

Info

Publication number
BR0112497A
BR0112497A BR0112497-8A BR0112497A BR0112497A BR 0112497 A BR0112497 A BR 0112497A BR 0112497 A BR0112497 A BR 0112497A BR 0112497 A BR0112497 A BR 0112497A
Authority
BR
Brazil
Prior art keywords
streptococcus pyogenes
antigens
pyogenes antigens
streptococcus
prophylaxis
Prior art date
Application number
BR0112497-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Denis Martin
Josee Hamel
Bernard R Brodeur
Stephane Rioux
Martine Boyer
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Publication of BR0112497A publication Critical patent/BR0112497A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0112497-8A 2000-07-06 2001-07-06 Antìgenos de streptococcus pyogenes BR0112497A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21646500P 2000-07-06 2000-07-06
PCT/CA2001/001001 WO2002004495A2 (en) 2000-07-06 2001-07-06 Streptococcus pyogenes antigen

Publications (1)

Publication Number Publication Date
BR0112497A true BR0112497A (pt) 2003-11-25

Family

ID=22807177

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112497-8A BR0112497A (pt) 2000-07-06 2001-07-06 Antìgenos de streptococcus pyogenes

Country Status (10)

Country Link
US (2) US7247308B2 (enExample)
EP (1) EP1297145B1 (enExample)
JP (1) JP4718099B2 (enExample)
AT (1) ATE412750T1 (enExample)
AU (1) AU7227001A (enExample)
BR (1) BR0112497A (enExample)
CA (1) CA2413576C (enExample)
DE (1) DE60136360D1 (enExample)
ES (1) ES2316458T3 (enExample)
WO (1) WO2002004495A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7227001A (en) * 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens
US7939087B2 (en) 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
DE60134494D1 (de) * 2000-12-21 2008-07-31 Id Biomedical Corp Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
WO2004018646A2 (en) * 2002-08-26 2004-03-04 Chiron Corporation Conserved and specific streptococcal genomes
PT1648500E (pt) 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Composições imunogénicas para estreptococos piogenes
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20090317420A1 (en) * 2004-07-29 2009-12-24 Chiron Corporation Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
US7838010B2 (en) * 2004-10-08 2010-11-23 Novartis Vaccines And Diagnostics S.R.L. Immunogenic and therapeutic compositions for Streptococcus pyogenes
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
DK2054431T3 (da) * 2006-06-09 2012-01-02 Novartis Ag Konformere af bakterielle adhæsiner
CA2668018A1 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
US8287885B2 (en) 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
AU2008339551B2 (en) 2007-12-21 2013-10-24 Glaxosmithkline Biologicals S.A. Mutant forms of streptolysin O
AU2012271336B2 (en) 2011-06-17 2017-03-02 University Of Tennessee Research Foundation Group A streptococcus multivalent vaccine
AU2014214613A1 (en) 2013-02-11 2015-08-13 University Of Tennessee Research Foundation Group A streptococcal M-related proteins and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916726A1 (en) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Attaching substances to micro-organisms
AU7227001A (en) 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens

Also Published As

Publication number Publication date
DE60136360D1 (de) 2008-12-11
JP4718099B2 (ja) 2011-07-06
US7247308B2 (en) 2007-07-24
JP2004502446A (ja) 2004-01-29
EP1297145B1 (en) 2008-10-29
ATE412750T1 (de) 2008-11-15
EP1297145A2 (en) 2003-04-02
WO2002004495A3 (en) 2002-06-13
CA2413576A1 (en) 2002-01-17
WO2002004495A2 (en) 2002-01-17
AU7227001A (en) 2002-01-21
US20030165528A1 (en) 2003-09-04
US20080038268A1 (en) 2008-02-14
ES2316458T3 (es) 2009-04-16
CA2413576C (en) 2012-11-13
US7811585B2 (en) 2010-10-12

Similar Documents

Publication Publication Date Title
BR0112497A (pt) Antìgenos de streptococcus pyogenes
BE2021C506I2 (enExample)
ATE227134T1 (de) Chitosan-impfstoff-zusammensetzungen zur intranasalen verabreichung und anwendungen
MX2023000411A (es) Vacuna combinada de sars-cov-2 e influenza.
MA29406B1 (fr) Vaccin toxoide alpha de c. perfringens
BR0114786A (pt) Composição imunogênica, método de tratamento de um paciente que sofre de, ou que é suscetìvel a, um câncer, e, uso de uma combinação de uma saponina, um oligotìdeo imunoestimulador e um antìgeno de câncer, e, método para a manufatura de uma composição
ATE542829T1 (de) Impfstoff
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
BRPI0408085A (pt) composição e método para o tratamento e prevenção de infecções entéricas bacterianas
AU2002360592A1 (en) Inhibitors of hepatitis c virus
BRPI0416205A (pt) uso de antibióticos como adjuvantes de vacina
WO2002036790A3 (en) Influenza virus vector for infection of dendritic cells
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
BRPI0113155C1 (pt) métodos para produção de uma vacina para hepatite b e de um antígeno de superfície para hepatite b
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
DE69835424D1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
EP1379556A4 (en) ANTI-PILYROSPORUM OVAL LGY AND ITS USE
EP1543838A4 (en) Vaccine against infectious CAT PERITONITIS
BR0114403A (pt) Polipeptìdeos de "haemophilus influenzae" que podem ser usados para fins de profilaxia, diagnóstico e/ou terapia
DE69824794D1 (de) Streptococcus equi Impfstoff
BR0210875A (pt) Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes
BRPI0512921A (pt) processo para tratamento e profilaxia de ms
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
BR0303500A (pt) Anticorpo monoclonal especìfico para um epìtope de glicoproteìna codificada pelo vìrus da imunodeficiência felina inativo

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: SHIRE BIOCHEM INC. (CA)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDA ATRAVES DA PETICAO NO 0200500112577/RJ DE 11/10/2005.

B25A Requested transfer of rights approved

Owner name: ID BIOMEDICAL CORPORATION (CA)

Free format text: TRANSFERIDO DE: SHIRE BIOCHEM INC.

B25G Requested change of headquarter approved

Owner name: ID BIOMEDICAL CORPORATION (CA)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018070070670/SP DE 24/10/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2313 DE 05-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.